Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: J Neurochem. 2013 Jul 22;126(5):591–603. doi: 10.1111/jnc.12345

Table 3.

Overview of Results about Tissue Catechols in Patients with Parkinson’s Disease (PD), Mice with Very Low Activity of the Type 2 Vesicular Monoamine Transporter (VMAT2-Lo), and Mice with Knockouts of Aldehyde Dehydrogenase 1A1 and 2 Genes (ALDH1A1,2)

Catechol PD VMAT2-Lo ALDH1A1, 2
DOPAL : DA
DA : DOPA ↓↓ ↓↓
DOPAC : DOPAL ↑↑ ↓↓
DOPAC : DA ↑↑
DOPET : DOPAC ↑↑ ↑↑

↑ Increased compared with controls.

↑↑↑ Markedly increased compared with controls (more than 5-fold).

↓ Decreased compared with controls.

↓↓ Markedly decreased compared with controls (less than 20%).

↔ Not significantly different from controls.